CPhI Announces 17th Annual CPhI Pharma Awards Winners

Article

The winners were announced during day seven of CPhI Festival of Pharma.

CPhI Worldwide announced the winners of the 17th annual CPhI Pharma Awards on Oct. 13, 2020 during the virtual Festival of Pharma event. The shortlist consisted of 13 different categories spanning across the pharmaceutical supply chain and included a total of 83 finalists of the industry’s companies and individuals. Winners were selected by a panel of independent, senior industry experts.

The winners included:

Excellence in Pharma: Analysis, Testing, and Quality Control

Merck, Blazar platform

Excellence in Pharma: API Development

Micropore Technologies, Membrane Crystallisation

Excellence in Pharma: Contract Services and Outsourcing

Arcinova FlowInova

Excellence in Pharma: Finished Formulation

Lonza Capsugel, Capsugel DBcaps

Highly commended: Uriach Italy—Colpofix

Excellence in Pharma: Manufacturing Technology and Equipment

FabRx, M3DIMAKER

Excellence in Pharma: Drug Delivery Devices

Nemera Safe’n’Spray

Highly commended: Ypsomed, SmartPilot for YpsoMate

Excellence in Pharma: Packaging

SCHOTT Pharmaceutical Systems, SCHOTT Smart Containers

Excellence in Pharma: Regulatory Procedures and Compliance

Affygility Solutions, OEL Fastrac platform

Excellence in Pharma: Supply Chain, Logistics, and Distribution

Controlant, Cold Chain as a Service (ChaaS)

Excellence in Pharma: Digital Innovation

Novartis Pharma Schweiz, The Advanced Myelofibrosis Risk Scoring Tool

Excellence in Pharma: Sustainability

Dr. Reddy’s Laboratories, Watershed Program

Excellence in Pharma: CEO of the Year

Bobby Sheng, Bora Pharmaceuticals

Excellence in Pharma: Innovation in Response to COVID-19

Beximco Pharmaceuticals

Highly commended: Ridgeback Biotherapeutics, MK-4482—in collaboration with Merck

People’s choice—chosen by event attendees

MedPharm

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content